Novel and Evolving Therapies for COVID-19 Related Pulmonary Complications

Link to article at PubMed

Am J Med Sci. 2021 Feb 25:S0002-9629(21)00072-0. doi: 10.1016/j.amjms.2021.02.019. Online ahead of print.


Coronaviruses disease 2019 (COVID-19) is the most crucial threat, the world has ever witnessed. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of this disease pandemic. The World Health Organization has confirmed the continuing epidemic as a worldwide public health crisis. Presently, the research on COVID-19 is even in the primitive stage. Studies on unveiling the natural route of COVID-19 infection and related pathophysiology, the biology of pulmonary airways pose a more rational restorative approach in the management of COVID-19. Thus, based on the existing facts, we methodically reviewed the efforts put forth by various research institutes, pharmaceutical companies and biotechnology firms in pulmonary delivery to prevent and control the COVID-19. This article would be valuable for the healthcare community, which is efficiently dealing with the SARS-CoV-2 crisis.

PMID:33640363 | PMC:PMC7906517 | DOI:10.1016/j.amjms.2021.02.019

Leave a Reply

Your email address will not be published. Required fields are marked *